OTLERTUZUMAB
UNII 2MZ3L2664T

Substance Identification & Data

This profile provides standardized clinical and technical data for Otlertuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2MZ3L2664T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1372645-37-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2MZ3L2664T

CAS Registry Number

1372645-37-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OTLERTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C74006

National Cancer Institute reference terminology for clinical and research data.

INN ID

9832

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-172

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Otlertuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.